3-hydroxybenzylhydrazine has been researched along with Hypercapnia in 1 studies
3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Monoamine synthesis in whole brain was measured during, and at various intervals after, hypercapnia by estimating the accumulation of dihydroxyphenylalanine (DOPA) and 5-hydroxytryptophan (5-HTP) after inhibition of aromatic L-amino-acid decarboxylase with NSD 1015." | 3.66 | Monoamine synthesis and concentration in neonatal rat brain during hypercapnia and recovery. ( Hedner, T; Lundborg, P, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hedner, T | 1 |
| Lundborg, P | 1 |
1 other study available for 3-hydroxybenzylhydrazine and Hypercapnia
| Article | Year |
|---|---|
Monoamine synthesis and concentration in neonatal rat brain during hypercapnia and recovery.
Topics: 5-Hydroxytryptophan; Animals; Animals, Newborn; Brain; Dihydroxyphenylalanine; Dopamine; Hydrazines; | 1982 |